Claiborne Cary J - Insider Stock Trading - OpenInsider

CIK: 1370930 - Address: 4870 Sadler Road, Ste 300, Glen Allen,, VA 23060

11 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
S	%ret	1	1	4	-0	3	-15	-6	-11	32	1
S	%wins				50	50	75	75	75	25	58

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
12/17/14 17:34	12/15/14	SCMP	Sucampo Pharmaceuticals, Inc.		Health	Drug	Pharmaceutical Preparations	Claiborne Cary J	MD	H	Former C	M.dm	204	4.07	5	50		3	D	157	58	74	95	54	9	-8	-8	0	-1	5	40	27	28
12/17/14 17:34	12/15/14	SCMP	Sucampo Pharmaceuticals, Inc.		Health	Drug	Pharmaceutical Preparations	Claiborne Cary J	MD	H	Former C	S.dm	-645	12.91	5	-50	-95	3	D	157	58	74	95	54	9	-8	-8	0	-1	5	40	27	28
2/28/14 18:53	2/27/14	SCMP	Sucampo Pharmaceuticals, Inc.		Health	Drug	Pharmaceutical Preparations	Claiborne Cary J	MD	O	CFO	M.d	10	4.07	2	3		0	D	38	82	59	22	-13	25	14	10	-6	-7	-26	-17	-23	68
2/28/14 18:53	2/27/14	SCMP	Sucampo Pharmaceuticals, Inc.		Health	Drug	Pharmaceutical Preparations	Claiborne Cary J	MD	O	CFO	S.d	-23	9.00	2	-3	-100	0	D	38	82	59	22	-13	25	14	10	-6	-7	-26	-17	-23	68
1/9/14 17:05	1/7/14	SCMP	Sucampo Pharmaceuticals, Inc.		Health	Drug	Pharmaceutical Preparations	Claiborne Cary J	MD	O	CFO	M.d	11	4.40	2	3		0	D	104	84	37	45	19	12	-2	0	2	19	-14	-20	-26	49
1/9/14 17:05	1/7/14	SCMP	Sucampo Pharmaceuticals, Inc.		Health	Drug	Pharmaceutical Preparations	Claiborne Cary J	MD	O	CFO	S.d	-23	9.00	2	-3	-100	0	D	104	84	37	45	19	12	-2	0	2	19	-14	-20	-26	49
5/22/13 17:06	5/20/13	SCMP	Sucampo Pharmaceuticals, Inc.		Health	Drug	Pharmaceutical Preparations	Claiborne Cary J	MD	O	CFO	S.m	-44	9.52	4	-5	-3	136	D	106	13	100	72	30	-1	-4	-5	3	2	-24	-28	-21	-16
12/29/09 10:33	12/24/09	NGBF	New Generation Biofuels Holdings, Inc	FL	Chem	OChm	Industrial Organic Chemicals	Claiborne Cary J	MD	DO	CEO,CFO,	P.m	14	0.7093	0	20	8	285	D
12/22/09 17:18	12/18/09	NGBF	New Generation Biofuels Holdings, Inc	FL	Chem	OChm	Industrial Organic Chemicals	Claiborne Cary J	MD	DO	CEO,CFO,	P.m	14	0.6991	0	20	8	265	D
3/2/07 14:17	3/2/07	OSIR	Osiris Therapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Claiborne Cary J	MD	O	CFO	M.d	6	0.4000	5	15	25	75	D			33	-32	-50	-37	-23	-16	1	-2	37	-17	-5	-25
9/28/06 11:17	9/27/06	OSIR	Osiris Therapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Claiborne Cary J	MD	O	CFO	M.d	18	0.4000	0	45	300	60	D					7	-4	-5	1	-1	2	44	153	78	22

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact